Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer

Prostate

Volumn 74, Issue 10, 2014, Pages 1043-1051

  Glybochko, P V ^a   Zezerov, E G ^a   Glukhov, A I ^a   Alyaev, Yu G ^a   Severin, S E ^a   Polyakovsky, K A ^a   Varshavsky, V A ^a   Severin, E S ^a   Vinarov, A Z ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

dynamic process of prostate carcinogenesis; precancer; prostate cancer; prostate specific antigen; prostatic intraepithelial neoplasia; telomerase

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FOLLOW UP; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LNCAP CELL LINE; LOW GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN BLOOD LEVEL; TRANSURETHRAL RESECTION;

DYNAMIC PROCESS OF PROSTATE CARCINOGENESIS; PRECANCER; PROSTATE CANCER; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TELOMERASE;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84901650296     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22823     Document Type: Article

References (36)

1. Alyaev YuG,. Urologiya (Urology). Moscow: "Meditsinskoye Informatsionnoye Agentstvo" ("Medical news agency"); 2005. p. 639. Russian.
2. Zezerov EG, Severin ES,. Molecular mechanisms of prostatic oncogenesis. Vestn Ross Akad Med Nauk 1998; (5): 29-35. Review. Russian.
3. Zezerov EG, Severin ES,. " Prostatic" kallikreins, sex hormones, and insulin-like growth factors: A complex of male and female regulatory elements in health and carcinogenesis. Vestn Ross Akad Med Nauk 1999; (3): 49-56. Review. Russian.
4. Zezerov EG,. Hormonal and molecular biological factors in pathogenesis of prostate cancer. Vopr Oncol 2001; 47 (2): 174-181. Review. Russian.
5. Altshuler ML, Severin SE, Glukhov AI,. Telomerase's in the light of modern representations about malignant transformation cells. Biochemistry (Mosc) 2003; 68 (12): 1587-1596. Russian.
6. Glukhov AI, Zimnik AI, Gordeyev SA, Severin SE,. Exploitation's the amplification of test-systems for the analysis of telomerase. Allergy Asthma Clin Immunol 1999; (9): 173-175. Russian.
7. Zezerov EG, Severin ES,. Molekularniye Mekhanismy Raka Predstatelnoy Zhelezy-Perspektivy Laboratornoy Diagnostiki I Lecheniya (Molecular mechanisms of prostate cancer-Laboratory diagnosis and treatment prospects). In:, Rakhamanin YuA, Beer SA, editors. Problems of biomedicine on the t u r n XXI centuri. Moscow: Edition of Russian Academy of Natural Sciences; 2000. pp. 92-103. Review. Russian.
8. Glukhov AI, Zimnik OV, Gordeev SA, Severin SE,. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. Biochem Biophys Res Commun 1998; 248: 368-371. (Pubitemid 28386428)
9. Glukhov AI, Apryatin SA, Siluyanova SN, Lesnichuk SA, Zikova ES, Vorobiyva SA, Andrianova LE, Borisov YuP,. Telomeraza kak Universalny Opukholevy Marker: Stroyenye, Funktsii i Diagnosticheskaya Tsennost (Telomerase as a universal tumor marker: Structure, functions, diagnostic value). Moscow: Izdatelstvo Moskovskoy Meditsinskoy; Akademii im IM Sechenova (Publishing house of the IM Sechenov Moscow medical academy) 2009. p. 43. Review. Russian.
10. Chieco P, Bertaccini A, Giovannini C, Stecca BA, Martorana G,. Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens. Eur Urol 2001; 40 (6): 666-672. (Pubitemid 34102536)
11. Orlando C, Gelmini S, Selli C, Pazzagli M,. Telomerase in urological malignancy. J Urol (Baltimore) 2001; 166 (2): 666-673. (Pubitemid 32652298)
12. Koeneman KS, Pan Ch-X, Jin JK, Pyle JM III, Flanigan RC, Shakey TV, Diaz MO,. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J Urol (Baltimore) 1998; 160 (4): 1533-1539. (Pubitemid 29480573)
13. Kamradt J, Drosse C, Kalkbrenner S, Rohde V, Lensch R, Lehmann J, Fixemer T, Bonkhoff H, Stoeckle M, Wullich B,. Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: Real-time quantification and in situ hybridization study. Lab Invest 2003; 83 (5): 623-633. (Pubitemid 36618041)
14. Joniau S, Goeman L, Pennings J, Van Poppel H,. Prostatic intraepithelial neoplasia (PIN): Importance and clinical management. Eur Urol 2005; 48 (3): 379-385. (Pubitemid 41188391)
15. Bostwick DG, Cheng L,. Precursor of prostate cancer. Histopathology 2012; 60 (1): 4-27.
16. Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A,. High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: Existence of HGPIN near prostate cancer. Prostate 2013; 73 (10): 1115-1122.
17. Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, Farley A, Jansz K, Siemens DR, Trpkov K, Lacombe L, Gleave M, Tu D, Parulekar WR,. Progression from high-grade prostatic intraepithelial neoplasia to cancer: A randomised trial of combination of vitamin-E, soy, and selenium. J Clin Oncol 2011; 29 (17): 2386-2390.
18. Laurila M, van der Kwast T, Bubendorf L, di Lollo S, Pihi CG, Ciatto S, Hugosson J, Määttänen L, Roobol MJ, Kujala PM,. Detection rates of cancer, high-grade PIN and atypical lesions suspicious for cancer in the European randomized study of screening for prostate cancer. Eur J Cancer 2010; 46 (17): 3068-3072.
19. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM Jr., Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila) 2011; 4 (11): 1761-1769.
20. Cheetham PJ, Katz AE,. Diet and prostate cancer-A holistic approach to management. Arch Esp Urol 2011; 64 (8): 720-734.
21. Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M,. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene. J Clin Oncol 2013; 31 (5): 523-529.
22. Roscigno M, Scattoni V, Freschi M, Abdollah F, Maccagnano C, Galosi A, Lacetera V, Montironi R, Muzzonigro G, Deho F, Deiana G, Belussi D, Chinaglia D, Montorsi F, Da Pozzo LF,. Diagnosis of isolated high-grade prostatic intraepithelial neoplasia: Proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy. BJU Int 2012; 109 (9): 1329-1334.
23. Braun M, Perner S,. High-grade prostatic intraepithelial neoplasia: The only accepted prostate cancer precursor lesion. Pathologe 2011; 32 (Suppl 2): 237-241.
24. Zezerov EG, Kovalenko NA, Zabezhinskaya OM, Lesnichuk SA, Kurynin RV, Aslamazov EG, Vinarov AZ, Bezrukov EA, Polyakovsky KA, Butnaru DV, Spirichev VB, Beketova NA, Pereverzeva OG, Popova ON, Barashkov GK, Zaitseva LI, Glukhov AI, Belushkina NN, Alyaev YuG,. Study of the clinical value of determination of the activity of telomerase, DNA ploidy, the blood content of vitamins, trace elements, and minor components and PSA-producing cell mRNA in diagnosing prostatic intraepithelial neoplasia, cancer prostate, and its micrometastases. Vopr Biol Med Pharm Chem 2005; (3): 44-54. Russian.
25. Kovalenko NA, Golovchenko KV, Lesnichuk SA, Alyaev YuG, Severin SE, Vinarov AZ, Zezerov EG, Glukhov AI, Severin ES,., Determination of the activity of telomerase in renal and prostatic tumors. Vopr Biol Med Pharm Chem 2003; (1): 21-25. Russian.
26. Rosai Ju,. General surgical pathology, vol. 1. 10th edition, Edinburgh, London, New York, Oxford: Philadelphia, St Louis, Sydney, Toronto: Mosby Elsevier; 2011. p. 3200.
27. Petersen RO, Sesterhenn IA, Davis CJ,. Urological pathology, 3rd edition Lippincott Wiliams and Wilkins; 2009. p. 609.
28. Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH,. Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer 2006; 6: 73-76.
29. Genes VS,. Nekotorye Prostye Metody Kiberneticheskoy Obrabotki Dannih Diagnosticheskih I Fiziologicheskih Issledovany (Several simple cybernetic processing methods of diagnostic and physiological data). Moscow: Izdatelstvo "Nauka" (Publishing house; "Science") 1967. p. 190. Russian.
30. Ashmarin IP, Vorobiev AA,. Statisticheskie Metodi v Mikrobiologicheskih Issledovaniyah (Statistical methods in microbiological studies). Leningrad: Gosudarstvennoe Izdatelstvo Meditsinskoy; Literaturi (The state publishing house of medical literature); 1962. p. 180 Russian.
31. Urbach VY,. Biometricheskie Metody (Biometric methods). Moscow: Izdatelstvo "Nauka" (Publishing house; "Science") 1964. p. 415. Russian.
32. Zezerov EG,. Ispolzovanie Statisticheskih Metodov dlya Standartizatsii Virusologicheskih Eksperimentov (The use of statistical methods for standardization of virological experiments). In:, Pshenichnov VA, Semenov BF, Zezerov EG, Standartizatsiya Metodov Virusologicheskih Issledovani (The standardization of research methods in virology). Moscow: Izdatelstvo "Meditsina" (Publishing house; "Medicine"); 1974. pp. 93-143. Russian.
33. Rokitskiy PF,. Biologicheskaya Statistika (Biological statistics). Minsk: Izdatelstvo "Visheyshaya Shkola" (Publishing; house "High school") 1973. p. 319 Russian.
34. De Marzo AM, Nelson WG, Meeker AK, Coffey DS,. Stem cell features of benign and malignant prostate epithelial cells. J Urol (Baltimore) 1998; 160 (6 Pt 2): 2381-2392. (Pubitemid 29483047)
35. Colli JL, Amling CL,. Chemoprevention of prostate cancer: What can be recommended to patients. Curr Prostate Urol Rep 2009; 10 (3): 165-171.
36. Klein EA, Thompson IM,. Chemoprevention of prostate cancer: An update view. World J Urol 2012; 30 (2): 189-194.